Aspen Pharmacare Holdings Limited
APN.JO
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.23B
Close$
Share Statistics
| Market cap | $4.23 Billion |
|---|---|
| Enterprise Value | $3.80 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | 1.92% |
|---|---|
| Return on Assets | 1.43% |
| Return on Invested Capital | 6.48% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.05 |
| Enterprise Value to EBIT | 0.64 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 4.06 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aspen Pharmacare Holdings Ltd
9,557 employees
CEO: Stephen Saad Operating worldwide, Aspen Pharmacare Holdings Limited, together with its subsidiaries, focuses on the development, production, and global distribution of specialized and branded pharmaceutical products. The company's business activities...